UPDATE 1-Integra LifeSciences Q2 profit beats Street

* Q2 adj EPS $0.68 beats Street by 4 cents

* Revenue rises 8 pct to $178.6 mln

* Backs fiscal 2010 outlook

July 29 (Reuters) - Medical device maker Integra LifeSciences Holdings Corp (IART.O) posted a better-than-expected quarterly profit, helped by strong sales in its orthopedics and neurosciences segments, and reiterated its full-year outlook.

For the second quarter, the company reported net income of $15.2 million, or 50 cents a share, compared with $11.2 million, or 38 cents a share, a year ago.

Excluding items, it earned 68 cents a share. Revenue rose 8 percent to $178.6 million.

Analysts on average expected earnings of 64 cents a share, excluding special items, on revenue of $176.3 million, according to Thomson Reuters I/B/E/S.

Orthopedics sales rose 12 percent to $72.8 million and neurosciences sales increased 8 percent to $66.3 million.

The company backed its full-year adjusted earnings view of $2.60 to $2.75 a share, on revenue of $715 million to $735 million.

Analysts on average were expecting earnings of $2.65 a share, on revenue of $725.2 million.

Shares of the company closed at $34.03 Wednesday on Nasdaq. (Reporting by Anand Basu in Bangalore)